Biotech Values

[dewophile]

i think if tL is approved that sets the stage for a buyout from NVS since the uncertainty over the value of mL will be lifted.
Despite NVS's position that they are pursuing a "European" model for FOBs, given recent FDA statements on FOBs and the long exclusivity garnered by mL based on the technology, i think they will be happy to not just keep all the lovenox revenue and own mC outright but also have their hands on the technology at a premium